- IN₹293.95m
- IN₹317.24m
- 12
- 20
- 47
- 12
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.29 | ||
| Price to Tang. Book | 3.13 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.97% | ||
| Return on Equity | -1.97% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 14.32 | 0.13 | 0.22 | 0.22 | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Samsrita Labs Limited is an India-based biopharma company. The Company is engaged in activities, such as trading, exports and imports, manufacturing of bulk drugs, research, and development (R&D) through joint ventures or associations or mergers or by its own. It has established platforms in the areas of stem cell research and therapy, new drug discovery, molecular prognosis and diagnostics services, CRO, stem cell focused super specialty hospital, RNA interference technology, and medical devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nanoformulation of cancer drugs, molecular genetics and molecular virology, stem cell, and cord blood banking. Its Molecular Prognosis and Diagnostics services division provides molecular diagnostics and services in the areas of cytogenetics, pharmacogenomics, pathology, radiology, hematology, biochemistry, and microbiology.
Directors
- Kalidindi Raju CHM (58)
- K. N. V. Kumar CFO
- Mohammed Habeeb NED (50)
- Syed Paspala NED (50)
- Y. Rama Reddy IND
- Aakanksha Shukla IND
- A. S. S. V. Srinivas IND
- Akka Jyothy NID
- Tennati Murthy NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 25th, 1996
- Public Since
- August 10th, 2015
- No. of Employees
- 3
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange- Shares in Issue
- 14,808,700
- Address
- 6-3-354/13/B2, Flat.No.B2, HYDERABAD, 500082
- Web
- https://drhlsl.com/
- Phone
- +91 2228520461
- Auditors
- M/s. MGR & Co.
Upcoming Events for 539267
Samsrita Labs Ltd Annual Shareholders Meeting
Similar to 539267
Aashka Hospitals
Bombay Stock Exchange
Abate As Industries
Bombay Stock Exchange
Asarfi Hospital
Bombay Stock Exchange
Aspira Pathlab & Diagnostics
Bombay Stock Exchange
Broach Lifecare Hospital
Bombay Stock Exchange
FAQ
What is the Samsrita Labs share price?
As of Today at 23:03 UTC, shares in Samsrita Labs are trading at IN₹18.91. This share price information is delayed by 15 minutes.
How has the Samsrita Labs share price performed this year?
Shares in Samsrita Labs last closed at IN₹18.91 and the price had moved by +13.57% over the past 365 days. In terms of relative price strength the Samsrita Labs share price has outperformed the S&P BSE 100 Index by +6.99% over the past year.
What are the analyst and broker recommendations for Samsrita Labs?
There is no consensus recommendation for this security.
Find out moreWhat is the Samsrita Labs dividend yield?
Samsrita Labs does not currently pay a dividend.
Does Samsrita Labs pay a dividend?
Samsrita Labs does not currently pay a dividend.
When does Samsrita Labs next pay dividends?
Samsrita Labs does not currently pay a dividend.
How do I buy Samsrita Labs shares?
To buy shares in Samsrita Labs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Samsrita Labs?
As of the previous close price of IN₹18.91, shares in Samsrita Labs had a market capitalisation of IN₹293.95m.
Where are Samsrita Labs shares listed?
Here are the trading details for Samsrita Labs:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 539267
What kind of share is Samsrita Labs?
Based on an overall assessment of its quality, value and momentum Samsrita Labs is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Samsrita Labs share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Samsrita Labs share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Samsrita Labs. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -14.59%.
As of the last closing price of IN₹18.91, shares in Samsrita Labs were trading -6.02% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Samsrita Labs PE Ratio?
The Samsrita Labs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹18.91.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Samsrita Labs?
Samsrita Labs' management team is headed by:
- Kalidindi Raju - CHM
- K. N. V. Kumar - CFO
- Mohammed Habeeb - NED
- Syed Paspala - NED
- Y. Rama Reddy - IND
- Aakanksha Shukla - IND
- A. S. S. V. Srinivas - IND
- Akka Jyothy - NID
- Tennati Murthy - NID